Addition of liraglutide to insulin in patients with type 1 diabetes: A randomized placebo-controlled clinical trial of 12 weeks
doi: 10.3389/fnut.2025.1615671 Received 21 April 2025 Accepted 29 July 2025 Published 13 August 2025 Volume 12 - 2025 Edited by Ismael San Mauro Martn, CINUSA Group, Spain Reviewed by Simone Birgit Bayer, University of Otago, Christchurch, New Zealand Emanuela Ribichini, Sapienza University of Rome, Italy Aleksandar Sic, Advocate Illinois Masonic Medical Center, United States Updates Copyright 2025 Khan, Brnstad, Hillestad, Steinsvik, Hausken, Berentsen and Lied
Sources Deane, A
This work creates a significant opportunity to improve patient outcomes while reducing unnecessary treatment costs by identifying which patients are most likely to respond to GLP-1 therapies
, ,
Talk to your doctor if you have concerns regarding missed doses